Search Results - "MESTECKY, Jiri"
-
1
Antibody-dependent passive protection of mucosal surfaces
Published in Human vaccines & immunotherapeutics (29-04-2022)“…Extensive experiments performed mostly in a variety of animal models convincingly demonstrated the protective effect of polyclonal or monoclonal antibodies…”
Get full text
Journal Article -
2
Mucosal Immunity in COVID-19: A Neglected but Critical Aspect of SARS-CoV-2 Infection
Published in Frontiers in immunology (30-11-2020)“…The mucosal immune system is the largest component of the entire immune system, having evolved to provide protection at the main sites of infectious threat:…”
Get full text
Journal Article -
3
Mucosal immunity: The missing link in comprehending SARS-CoV-2 infection and transmission
Published in Frontiers in immunology (17-08-2022)“…SARS-CoV-2 is primarily an airborne infection of the upper respiratory tract, which on reaching the lungs causes the severe acute respiratory disease,…”
Get full text
Journal Article -
4
Role of IgA1 protease-producing bacteria in SARS-CoV-2 infection and transmission: a hypothesis
Published in mBio (29-08-2024)“…Secretory (S) IgA antibodies against severe acute respiratory syndrome (SARS)-CoV-2 are induced in saliva and upper respiratory tract (URT) secretions by…”
Get full text
Journal Article -
5
Enhancing oral vaccine potency by targeting intestinal M cells
Published in PLoS pathogens (01-11-2010)“…The immune system in the gastrointestinal tract plays a crucial role in the control of infection, as it constitutes the first line of defense against mucosal…”
Get full text
Journal Article -
6
Galactose-Deficient IgA1 B cells in the Circulation of IgA Nephropathy Patients Carry Preferentially Lambda Light Chains and Mucosal Homing Receptors
Published in Journal of the American Society of Nephrology (01-05-2022)“…IgA nephropathy (IgAN) primary glomerulonephritis is characterized by the deposition of circulating immune complexes composed of polymeric IgA1 molecules with…”
Get full text
Journal Article -
7
Mucosal immunoglobulins
Published in Immunological reviews (01-08-2005)“…Due to their vast surface area, the mucosal surfaces of the body represent a major site of potential attack by invading pathogens. The secretions that bathe…”
Get full text
Journal Article -
8
The Origin and Activities of IgA1-Containing Immune Complexes in IgA Nephropathy
Published in Frontiers in immunology (12-04-2016)“…IgA nephropathy (IgAN) is the most common primary glomerulonephritis, frequently leading to end-stage renal disease, as there is no disease-specific therapy…”
Get full text
Journal Article -
9
IgA Glycosylation and IgA Immune Complexes in the Pathogenesis of IgA Nephropathy
Published in Seminars in nephrology (2008)“…Summary Circulating immune complexes containing aberrantly glycosylated IgA1 play a pivotal role in the pathogenesis of IgA nephropathy (IgAN). A portion of…”
Get full text
Journal Article -
10
IgA Nephropathy: Pleiotropic impact of Epstein-Barr virus infection on immunopathogenesis and racial incidence of the disease
Published in Frontiers in immunology (07-02-2023)“…IgA nephropathy (IgAN) is an autoimmune disease in which poorly galactosylated IgA1 is the antigen recognized by naturally occurring anti-glycan antibodies,…”
Get full text
Journal Article -
11
Two Cells, One Antibody: The Discovery of the Cellular Origins and Transport of Secretory IgA
Published in The Journal of immunology (1950) (01-03-2017)Get full text
Journal Article -
12
IgA nephropathy: molecular mechanisms of the disease
Published in Annual review of pathology (24-01-2013)“…Studies of molecular and cellular interactions involved in the pathogenesis of IgA nephropathy have revealed the autoimmune nature of this most common primary…”
Get full text
Journal Article -
13
Perspectives on Mucosal Vaccines: Is Mucosal Tolerance a Barrier?
Published in The Journal of immunology (1950) (01-11-2007)“…Mucosal administration of Ags induces specific Abs in external secretions and systemic unresponsiveness termed oral or mucosal tolerance. The dominant response…”
Get full text
Journal Article -
14
Aberrant IgA1 Glycosylation Is Inherited in Familial and Sporadic IgA Nephropathy
Published in Journal of the American Society of Nephrology (01-05-2008)“…IgA nephropathy (IgAN) is a complex trait determined by genetic and environmental factors. Most IgAN patients exhibit a characteristic undergalactosylation of…”
Get full text
Journal Article -
15
Glycosylation of IgA1 and pathogenesis of IgA nephropathy
Published in Seminars in immunopathology (01-05-2012)“…IgA nephropathy, described in 1968 as IgA-IgG immune-complex disease, is an autoimmune disease. Galactose-deficient IgA1 is recognized by unique…”
Get full text
Journal Article -
16
Glycosylation Patterns of HIV-1 gp120 Depend on the Type of Expressing Cells and Affect Antibody Recognition
Published in The Journal of biological chemistry (02-07-2010)“…Human immunodeficiency virus type 1 (HIV-1) entry is mediated by the interaction between a variably glycosylated envelope glycoprotein (gp120) and host-cell…”
Get full text
Journal Article -
17
Secretory IgA N-glycans contribute to the protection against E. coli O55 infection of germ-free piglets
Published in Mucosal immunology (01-03-2021)“…Mucosal surfaces are colonized by highly diverse commensal microbiota. Coating with secretory IgA (SIgA) promotes the survival of commensal bacteria while it…”
Get full text
Journal Article -
18
Role of Epstein-Barr Virus in Pathogenesis and Racial Distribution of IgA Nephropathy
Published in Frontiers in immunology (28-02-2020)“…IgA nephropathy (IgAN) is the dominant type of primary glomerulonephritis worldwide. However, IgAN rarely affects African Blacks and is uncommon in African…”
Get full text
Journal Article -
19
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells
Published in PLoS pathogens (01-11-2013)“…The mechanisms by which human immunodeficiency virus type 1 (HIV-1) crosses mucosal surfaces to establish infection are unknown. Acidic genital secretions of…”
Get full text
Journal Article -
20
Differences in serum IgA responses to HIV-1 gp41 in elite controllers compared to viral suppressors on highly active antiretroviral therapy
Published in PloS one (03-07-2017)“…Mechanisms responsible for natural control of human immunodeficiency type 1 (HIV) replication in elite controllers (EC) remain incompletely defined. To…”
Get full text
Journal Article